An Unbiased View of cancer research
A much better Biomarker for Cancer Immunotherapy? Posted: November 3, 2023 A completely new review, done largely in mice, could support reveal why a now used molecular marker—referred to as mismatch mend deficiency—doesn’t generally work to predict which patients will reply to immunotherapies termed immune checkpoint inhibitors.Skip to key in